BB-PROTAC

N/A

Report date: 2023/03/02 14:47:12

NME

Base Information

Drug NameBB-PROTAC

Drug Alias NameN/A

ClassificationSmall molecules > Proteolysis-Targeting Chimera (PROTAC)

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsAutoimmune DiseasesNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaPreclinical

Originator CompaniesBroadenbio Co Ltd

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsAutoimmune DiseasesNeoplasms

Inactive IndicationsN/A

ATC CodeN/A